Leading the Way in Colorectal Surgery
Leading the Way in Colorectal Surgery

One in four colorectal procedures result in readmission due to complications in the first 90 days.1 This represents a significant economic burden for hospitals.  Our goal is to help improve outcomes, reduce costs and improve patient experience.

Shaping the Future of Surgery

Over a Century of Meaningful Innovation

At Ethicon, weʼre focused on improving health outcomes for patients and helping solve the greatest health challenges… with only meaningful innovation. The kind that led to the creation of the first sutures, that helped revolutionize surgery with minimally invasive procedures, and that elevates standards of care around the world.

News & Events
Teaser Image
Ethicon Announces 510(K) Clearances for VISTASEAL Open and Laparoscopic Dual Applicator Devices Designed to Deliver Biologics That Address Surgical Bleeding
VISTASEAL Dual Applicator is the First Product to Emerge from Recent Strategic Partnership Between Ethicon and Grifols, Leading Maker of Plasma-Derived Medicines
Teaser Image
Pulmonary Artery Branch Sealing with Ultrasonic Energy Device Shows Promise in Minimally Invasive Lung Cancer International Clinical Trial
Preliminary Findings Presented at American Association for Thoracic Surgery Annual Meeting
Teaser Image
LINX Reflux Management System Has Been Shown to Reduce Medical Costs More Than Traditional Anti-Reflux Surgery in First Year Following Procedure
New Study Shows LINX treatment Lowers Overall Medical Expenses for GERD and other Health Issues
Teaser Image
Ethicon Launches Global Registry to Collect Real-World Data on Liver Lesions Ablated With the Neuwave Microwave Ablation System
References

* Benchtop testing in porcine tissue ≤30mmHg (26mmHg average pressure experienced during intra-operative leak test), comparing Ethicon ECHELON CIRCULAR™ Powered Stapler CDH25P to Medtronic DST Series™ EEA™ Stapler EEA2535 (p<0.001) and preclinical perfusion model, in which perfusion was not significantly different between devices.

†DRG market data from July 2016 – June 2017, comparing market share in colorectal procedures.

§Benchtop testing in porcine colon compared the rate of staple line leak failure at ≤30mmHg, compared Ethicon CDH29P and CS40B/CR40B or PSEE45A/GST45B to Medtronic EEA2835/EGIAUSTND and EGIARADMT or EGIA45AMT, n=60 ea p<0.001. Leak rate at ≤30mmHg was selected based on a preclinical study that measured the intraluminal pressure associated with an intra-operative leak test by surgeons (n=31). Average selected pressure was 26 +/-1.8 mmHg.

1.Wick EC, Shore AD, Hirose K, et al. Readmission rates and cost following colorectal surgery. Dis Colon Rectum. 2011; 54(12):1475-1479.

2.Lissovoy, G. D., Fraeman, K., Hutchins, V., Murphy, D., Song, D., & Vaughn, B. B. (2009). Surgical site infection: Incidence and impact on hospital utilization and treatment costs. American Journal of Infection Control, 37(5), 387-397.

3.Ming X, Rothenburger S, Nichols MM. In vivo and in vitro antibacterial efficacy of PDS Plus (polidioxanone with triclosan) suture. Surg Infect (Larchmt). 2008;9(4):451-457.

4.Ming X, Rothenburger S, Nichols MM, Rothenburger S. In Vivo Antibacterial Efficacy of MONOCRYL Plus Antibacterial (Poliglecaprone 25 withTriclosan) Suture. Surg Infect (Larchmt). 2007; 8(2):1-5.

5.Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobialevaluation of coated Vicryl Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect (Larchmt). 2002;3 (suppl):S79-S87.

6. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection,2017. JAMA Surg. doi:10.1001/jamasurg.2017.0904.

7. WHO Global Guidelines for the Prevention of Surgical Site Infection, 2016.

8. Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2016;224:59-74.

9. 100326296: Time Zero Tissue Holding - Competitive Claims Comparisons for STRATAFIX Knotless Tissue Control Devices vs Various Products. 2015.

10. Performance Testing of STRATAFIX SYMMETRIC PDS PLUS Size 0 & 1 Devices – Initiation Strength in Porcine Tissue. AST-2013-0603.

11. AST-2013-0056 Performance Testing of STRATAFIX Symmetric PDSSize2-0suture device for Tissue Holding Strength with Multiple Incision Defects to Measure Gapping.

12. Ethicon study PSE 09-0204, project number 11822. Exploratory histological and biomechanical evaluation of DOLFIN following closure of the ventral abdominal wall in a porcine model at 7±1 days. Approved on July 7, 2010.

13. Ethicon Performance Evaluation Memo AST-2012-0510. Performance Testing of STRATAFIX Symmetric Size 2-0 suture device for Tissue Holding Strength with an Incision Defect to Measure Gapping. Dated December 3, 2012.

14. STRATAFIX Symmetric PDS Plus Knotless Tissue Control Device. Instructions for Use. Ethicon, Inc.

15. Coated VICRYL Plus Antibacterial (polyglactin 910) Sutures Instructions for Use. Ethicon, Inc.